Oura CEO talks potential IPO and ‘nonnegotiable’ data privacy
Oura Health CEO Tom Hale, in a New York Times interview, avoided discussing new funding valuing the company at $11 billion but addressed potential plans for taking Oura public.
MAIN POINTS
- Tom Hale, CEO of Oura Health, was interviewed by The New York Times.
- He did not comment on reports of new funding valuing Oura at $11 billion.
- The discussion included whether there are plans to take Oura public.
- The focus was on the company's future rather than current financial valuations.
TAKEAWAYS
- Oura Health is reportedly valued at nearly $11 billion.
- The CEO is considering the possibility of an IPO for Oura.
- Financial discussions were not the focus of the interview.
- The company's growth and future plans were highlighted.